肥胖导致脂肪组织慢性炎症的新机制:脂肪细胞源性外泌体miR-32经旁分泌促进巨噬细胞向M1型极化

批准号:
82000813
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
王亚荻
依托单位:
学科分类:
能量代谢调节异常与肥胖
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
王亚荻
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
肥胖所致的脂肪组织慢性炎症是引发糖尿病,心血管疾病等代谢性疾病的重要原因,但肥胖如何驱动脂肪组织慢性炎症具体机制不明。肥胖状态下,脂肪细胞源性外泌体miRNA经旁分泌促进脂肪组织巨噬细胞(ATMs)向M1极化可能是导致脂肪组织慢性炎症的新机制。我们前期发现,高脂饮食诱导的肥胖小鼠脂肪细胞源性外泌体miR-32分泌显著增加,miR-32敲除上调ATMs中KLF4表达,显著改善肥胖小鼠脂肪组织慢性炎症。我们提出科学假说:脂肪细胞源性外泌体miR-32以旁分泌方式靶向负调控KLF4,诱导ATMs向促炎M1型极化,促进肥胖所致的脂肪组织慢性炎症。本项目将结合临床及体内外实验,利用脂肪细胞特异性敲除及过表达小鼠模型,应用KLF4过表达及沉默病毒,明确肥胖状态下,脂肪细胞源性外泌体miR-32能否及如何调节ATMs向M1极化,为防治肥胖所致的脂肪组织慢性炎症提供新的理论依据。
英文摘要
Obesity-induced chronic inflammation in adipose tissue is considered a crucial event for the development of metabolic diseases such as T2DM and cardiovascular diseases. The triggers for obesity-induced chronic adipose tissue inflammation are still poorly defined. Evidences suggest that adipocyte-derived exosomal miRNA could facilitate M1-like macrophages polarization in a paracrine manner, which may be a new mechanism for obesity-induced chronic adipose tissue inflammation. In our previous research, we found that adipocytes derived from epididymal adipose tissue obtained from obese mice released more exosomal miR-32 than adipocytes derived from lean mice. miR-32 knockout up-regulated KLF4 expression in ATMs and significantly improved chronic inflammation of adipose tissue in obese mice. Hence, we hypothesized that adipocyte-derived exosomal miR-32, represents a paracrine signaling system, whereby proinflammatory ATMs may result in obesity-induced chronic adipose tissue inflammation. We will combine clinical and the in vivo/vitro experiments to establish miR-32 knockout/transgenic mice model and KLF4 lentivirus to investigate whether and how the adipocyte-derived exosomal miR-32 can facilitate proinflammatory ATMs during obesity. Thus, our research will provide a new therapeutic target for obesity-induced chronic adipose tissue inflammation.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.metabol.2023.155660
发表时间:2023-07
期刊:Metabolism: clinical and experimental
影响因子:--
作者:Ya-Di Wang;Liang-Liang Wu-Liang;Yun Mai;Kai Wang;Yi Tang;Qi-Yu Wang;Jiaoyang Li;Li-Yan Jiang;Zhe-Zhen Liao;Can Hu;Yuan-yuan Wang;Jing-jing Liu;Jiang-Hua Liu;X. Xiao
通讯作者:Ya-Di Wang;Liang-Liang Wu-Liang;Yun Mai;Kai Wang;Yi Tang;Qi-Yu Wang;Jiaoyang Li;Li-Yan Jiang;Zhe-Zhen Liao;Can Hu;Yuan-yuan Wang;Jing-jing Liu;Jiang-Hua Liu;X. Xiao
New insight of obesity-associated NAFLD: Dysregulated “crosstalk” between multi-organ and the liver?
DOI:https://doi.org/10.1016/j.gendis.2021.12.013
发表时间:2021
期刊:Genes & Diseases
影响因子:6.8
作者:Wang YD;Wu LL;Qi XY;Wang YY;Liao ZZ;Liu JH;Xiao XH
通讯作者:Xiao XH
DOI:10.3389/fendo.2022.839849
发表时间:2022
期刊:Frontiers in endocrinology
影响因子:5.2
作者:Wang YY;Wang YD;Qi XY;Liao ZZ;Mai YN;Xiao XH
通讯作者:Xiao XH
DOI:10.1210/endocr/bqac062
发表时间:2022
期刊:Endocrinology
影响因子:--
作者:Kai Wang;Yuan-Yuan Wang;Liang-Liang Wu;Li-Yan Jiang;Yin Hu;Xin-Hua Xiao;Ya-Di Wang
通讯作者:Ya-Di Wang
国内基金
海外基金
